Navigation Links
Holiday Gifts for Those With Disabilities & Other Special Needs
Date:10/18/2007

visit the store due to their disability or lack of proximity," says Alonso. "With this online option, our customers can do it all from their own computer no matter where they live."

Rehability, Good Shepherd's 3,300-square-foot walk-in and online store, debuted in 2006 with a lifestyle product line that includes products for recreation, wellness, communication, education, home and daily living, mobility, vision and children's merchandise. For more information, please visit http://www.rehabilitystores.com.

More than 36,000 people come to Good Shepherd each year for specialized programs in stroke, orthopedics, brain injury, spinal cord injury, pediatrics, amputation and more. For more information about Good Shepherd, visit http://www.goodshepherdrehab.org.


'/>"/>
SOURCE Good Shepherd Rehabilitation Network
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Indian Surgeon Conducts 70 Surgeries During His Holidays In England
2. Holiday Season Can Lead to Weight Gain
3. Iranian Government Declares Holiday Due To Pollution
4. Holiday giving linked to altruistic nature of our ancestors
5. Holidays help in better management of stress
6. Reports Of A HIV Break Out Scare People Of A Holiday Island
7. Delhi Hospitals Cancel Holidays And Recalls Doctors
8. Holiday Season Could Ring in “Heartburn Season
9. Buy Children Holiday Gifts That Encourage Physical Activity
10. Holiday Gluttony Can Spell Disaster for Undiagnosed Diabetics
11. AAD Warns Against Indoor Tanning for the Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 1The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 2Millions Flowing into Medical Real Estate 13292 1Millions Flowing into Medical Real Estate 13292 2Millions Flowing into Medical Real Estate 13292 3Insurance Department Releases Report on Executive Compensation at States Largest Blues Plans 53231 1Insurance Department Releases Report on Executive Compensation at States Largest Blues Plans 53231 2